Melanotan 2 Peptide

What Melanotan 2 is

Melanotan 2 is a synthetic analogue of alpha-melanocyte-stimulating hormone. It prompts melanocytes to produce more melanin, which darkens skin with less ultraviolet exposure than would otherwise be needed. It is supplied for research use and is not a licensed medicine in the UK or anywhere else. This section carries 18 lines from £38 to £232, clustered near £72.

It is among the more side-effect-heavy peptides stocked here, and the effects are noticeable rather than subtle.

What people actually report

Commonly reported effects, by how frequently they appear

Effect	Frequency	Notes
Nausea	Very common	Worst in the first days; often dose-related
Facial flushing	Common	Transient, shortly after dosing
Darkening of moles and freckles	Common	The one that warrants attention — see below
Spontaneous erections	Common in men	Related mechanism to PT-141
Appetite suppression	Reported	Variable

The mole issue, stated plainly

Melanotan 2 stimulates melanocytes generally, not selectively. Existing moles commonly darken and new pigmented lesions are reported. That matters because darkening and change in a mole are also the warning signs of melanoma — so the compound obscures exactly the signal dermatologists rely on.

Anyone using it should have existing moles documented beforehand and any change assessed by a clinician rather than attributed to the peptide by default. This is the strongest single caution in this category and it is routinely omitted from product pages.

How it is typically approached

Protocols divide into a loading phase and a maintenance phase — more frequent dosing until the desired pigmentation is reached, then infrequent dosing to hold it. Most reported side effects cluster in the loading phase, which is why gradual escalation is the near-universal recommendation.

Because the compound acts on melanocortin receptors that are not confined to skin, the nausea and flushing are mechanistic rather than impurity-related. They generally diminish with continued use, though not in everyone.

The related compound

PT-141, also stocked in the broader peptides range, is a derivative of this same molecule developed for a different melanocortin effect entirely. The overlap explains why spontaneous erections are among the commonly reported effects of Melanotan 2 — the two compounds share a receptor family.

It does not remove the need for sun protection

Increased melanin offers some photoprotection, and “some” is doing considerable work in that sentence. It is not equivalent to sunscreen and does not license extended unprotected exposure. Several reported cases of skin damage involve exactly that assumption.

What the evidence base looks like

Melanotan 2 was developed from research at the University of Arizona into photoprotection, and the mechanism is well characterised. What was never completed is the clinical development that would establish safe dosing, long-term effects or a proper adverse-event profile in humans.

That is why the side effects listed above come from user reports rather than trial data, and why the mole-monitoring caution matters so much — nobody has systematically studied what sustained melanocyte stimulation does over years.

Why it is priced as it is

At £38 to £232 with a midpoint of £72, this sits mid-range for the peptide category. It is a relatively short sequence and inexpensive to synthesise, so the pricing reflects presentation size rather than production difficulty. A cheap listing here is unremarkable, unlike in the growth hormone category.

Why the fragment approach was tried

Growth hormone produces both fat metabolism and tissue growth, and the growth side brings the insulin-resistance concern that limits long-term somatropin use. Isolating the region responsible for lipolysis was a reasonable attempt to separate the two.

Whether it succeeded well enough to matter is the open question, and the AOD-9604 trial history is the most informative evidence available on that point.

Handling and legal position

Supplied lyophilised, reconstituted with bacteriostatic water, refrigerated afterwards. Not a controlled drug but an unlicensed medicine — supply for human use is an offence, possession generally is not. See are peptides legal in the UK and the broader risk picture in peptide side effects.

Ultima Pharmaceuticals and Pharmaqo Labs carry the stocked lines at 10 mg, alongside the wider peptides range.

Frequently asked questions

How long does Melanotan 2 take to tan?
Reports describe visible change over one to two weeks with some UV exposure. It requires that exposure — it accelerates tanning rather than replacing sunlight.

Can Melanotan 2 affect the kidneys?
Renal effects are not among the commonly reported issues. Nausea, flushing and pigmentation changes are.

How long does Melanotan 2 last in the body?
The peptide itself clears within roughly a day, but the pigmentation it produces persists for weeks as melanin turns over.

Do I still need sunscreen?
Yes. Additional melanin provides partial photoprotection at best and is not a substitute.

Why does it cause nausea?
It acts on melanocortin receptors that are not confined to skin, including some involved in appetite and nausea pathways.